Amendment to Drug Trials Rules In recent years, India has made a name for itself in the international pharmaceutical arena as a preferred destination for leading global companies to conduct clinical trials and there exists a basic regulatory regime governing the conduct of clinical trials. In due course of time, adequate knowledge of good clinical… Continue reading Ethical & Regulatory Issues in Conducting Clinical Trials in India
Tag: biotechnology
Bioscience Business In Asia Pacific (APAC): 10 Challenges
Recently, expert opinion of Advocate Rahul Dev, Bioscience Business Lawyer & Patent Attorney, was published in cover story of BioSpectrum Asia. Life sciences companies face a number of challenges while operating in the Asia Pacific region. BioSpectrum takes a look at 10 such challenges. Opportunities in the Asia Pacific region come with a set of… Continue reading Bioscience Business In Asia Pacific (APAC): 10 Challenges
Compulsory Licensing of Bayer’s Patented Cancer Drug Sorafenib Granted to Natco Pharma in India
India Allows Compulsory Licensing of Bayer The decision is likely to open up the field for the generics industry or force innovative companies to make drugs more affordable. But will it also affect innovation? BioSpectrum explores the two sides of the story The globally watched case related to an Indian pharma company's request to the… Continue reading Compulsory Licensing of Bayer’s Patented Cancer Drug Sorafenib Granted to Natco Pharma in India
NIH Stem Cell Injunction Vacated by the U.S. Court of Appeals for the D.C. Circuit
The federal government can continue funding research using human embryonic stem cells, the U.S. Court of Appeals for the D.C. Circuit ruled today, reversing a lower court injunction against the National Institutes of Health. Two scientists who work with adult stem cells sued NIH to stop embryonic stem cell research, charging that revised 2009 guidelines… Continue reading NIH Stem Cell Injunction Vacated by the U.S. Court of Appeals for the D.C. Circuit
Patents & Venture Capital Investments
It is very important for entrepreneurs’ startups and Small and medium enterprises (SMEs) to know how patent applications and grants held by new ventures improve their ability to attract venture capital (VC) financing. Generally, investors are faced with significant ambiguity and hence they rely on patents as indicators for calculating the potential of companies. It… Continue reading Patents & Venture Capital Investments
Law Office of Rahul Dev 